Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease

This publication has 25 references indexed in Scilit:

• HIGH HOMOCYSTEINE, LOW FOLATE, AND LOW VITAMIN B6 CONCENTRATIONS
  Transplantation, 1998
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
  Published by American Medical Association (AMA) ,1995
• Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study
  Atherosclerosis, 1995
• Vitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
  Journal of Nutrition, 1994
• Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
  JAMA, 1993
• Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment
  Atherosclerosis, 1993
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
  Published by American Medical Association (AMA) ,1992
• Serum homocysteine in routine evaluation of potential vitamin B₁₂ and folate deficiency
  European Journal of Haematology, 1990
• Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.
  Journal of Clinical Investigation, 1988
• Folic acid—an innocuous means to reduce plasma homocysteine
  Scandinavian Journal of Clinical and Laboratory Investigation, 1988